Brandon BioCatalyst

Brandon Capital is Australasia's leading life science venture capital firm, with a strong global presence supported by key partnerships and team members across the US and UK. Through collaboration and investment, we transform promising medical research breakthroughs into medical therapies that improve patients' lives. We have supported more than 50 start-up companies to date, the majority of which were founded by us in collaboration with the inventor and their research institutes. From early-stage seed investment through to expansion capital, Brandon Capital supports life science companies from proof-of-concept through to commercialization.